Compare Cassava Sciences Inc (FLNA) vs Kymera Therapeutics Inc. Common Stock (KYMR) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Cassava Sciences Inc vs Kymera Therapeutics Inc. Common Stock — how do they compare? Cassava Sciences Inc trades at $0.71 (market cap $35.34M), while Kymera Therapeutics Inc. Common Stock trades at $106.81 (market cap $8.88B). The key difference: Kymera Therapeutics Inc. Common Stock is far larger — about 251.3× Cassava Sciences Inc's market cap, and Kymera Therapeutics Inc. Common Stock is trading nearer its 52-week high, Cassava Sciences Inc nearer its low. Which is the better fit depends on your goals — on Pluang, investors hold Cassava Sciences Inc for 38 Days and Kymera Therapeutics Inc. Common Stock for 0 Days on average.
| FLNA | KYMR | |
|---|---|---|
Market Cap | $35.34M | $8.88B |
Volume | 251,946 | 1,028,790 |
Sector | Health | Health |
52-Week High | $4.64 | $127.31 |
52-Week Low | $0.68 | $55.80 |
Typical Hold Time | 38 Days | 0 Days |
Enterprise Value | -$47.34M | $8.27B |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
About Cassava Sciences Inc
Cassava Sciences Inc is a clinical-stage biotechnology company engaged in developing a scientific approach for the treatment and detection of Alzheimer's disease. Its therapeutic product candidate is called simufilam, and it is a novel treatment for Alzheimer's disease
Read more on FLNA →About Kymera Therapeutics Inc. Common Stock
Kymera Therapeutics, Inc. is a biopharmaceutical company developing small-molecule medicines based on targeted protein degradation, using its Pegasus platform to direct the body's natural protein-disposal system against disease-causing proteins.
Read more on KYMR →
